menu Search
Febucid

Febucid

febuxostat

Manufacturer:

Darya-Varia
Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Indications/Uses Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions MIMS Class ATC Classification Regulatory Classification Presentation/Packing
Full Prescribing Info
Contents
Febuxostat.
Description
Each film-coated tablet contains: Febuxostat 40 mg or 80 mg.
Indications/Uses
Treatment of chronic hyperuricemia in conditions where urate deposition has already occurred.
Dosage/Direction for Use
The recommended oral dose of febuxostat is 80 mg once daily without regard to food. If serum uric acid is >6 mg/dL (357 μmol/L) after 2-4 weeks and risk factor modification has failed, febuxostat 120 mg once daily may be considered.
Contraindications
Hypersensitivity to the active substance or to any ingredients in drugs.
Patients being treated with azathioprine or mercaptopurine.
Special Precautions
The safety and the efficacy of febuxostat in children below the age of 18 years have not been established. No data are available.
Adverse Reactions
The most commonly reported adverse reactions and post-marketing experience are gout flares, liver function abnormalities, diarrhoea, nausea, headache, arthralgia, rash and oedema.
View ADR Reporting Link
Drug Interactions
Mercaptopurine/azathioprine, CYP2C8 substrates, Theophylline, Naproxen or other inhibitors of glucuronidation, Inducers of glucuronidation, Colchicine/indomethacin/hydrochlorothiazide/warfarin, Desipramine/CYP2D6 substrates.
MIMS Class
Hyperuricemia & Gout Preparations
ATC Classification
M04AA03 - febuxostat ; Belongs to the class of preparations inhibiting uric acid production. Used in the treatment of gout.
Presentation/Packing
Form
Febucid FC tab 40 mg
Packing/Price
3 × 10's (Rp120,000/boks)
Form
Febucid FC tab 80 mg
Packing/Price
3 × 10's (Rp240,000/boks)
Iklan
Iklan
Iklan
Iklan
Iklan
Iklan